⌘K

Login Start Free

Home/Filings/4/0001144204-10-051896

4//SEC Filing

Farah John M JR 4

Accession 0001144204-10-051896

CIK 0001261734other

View on SEC.gov Company Profile

Filed

Sep 30, 8:00 PM ET

Accepted

Oct 1, 12:10 PM ET

Size

7.8 KB

Accession

0001144204-10-051896

Insider Transaction Report

Form 4

Period: 2010-02-16

AEOLUS PHARMACEUTICALS, INC.AOLS

Farah John M JR

Director

Transactions

Award
Non-Qualified Stock Option (right to buy)
2010-07-29+11,250→ 11,250 total
Exercise: $0.40Exp: 2020-07-29→ Common Stock (11,250 underlying)
Award
Non-Qualified Stock Option (right to buy)
2010-04-28+11,250→ 11,250 total
Exercise: $0.39Exp: 2020-04-28→ Common Stock (11,250 underlying)

Footnotes (1)

[F1]Option will vest monthly beginning on the grant date for twelve months, provided that the Director remains on the Board of Directors of the Company.

Documents

1 file

4
v196749_ex.xmlPrimary

Issuer

AEOLUS PHARMACEUTICALS, INC.

CIK 0001261734

Entity typeother

Related Parties

1

filerCIK 0001342458

Filing Metadata

Form type: 4
Filed: Sep 30, 8:00 PM ET
Accepted: Oct 1, 12:10 PM ET
Size: 7.8 KB

View on SEC.gov